137 related articles for article (PubMed ID: 2442732)
1. Peptide-hormone- and serotonin-immunoreactive tumour cells in carcinoma of the prostate.
Abrahamsson PA; Wadström LB; Alumets J; Falkmer S; Grimelius L
Pathol Res Pract; 1987 Jun; 182(3):298-307. PubMed ID: 2442732
[TBL] [Abstract][Full Text] [Related]
2. Peptide-hormone- and serotonin-immunoreactive cells in normal and hyperplastic prostate glands.
Abrahamsson PA; Wadström LB; Alumets J; Falkmer S; Grimelius L
Pathol Res Pract; 1986 Dec; 181(6):675-83. PubMed ID: 2436200
[TBL] [Abstract][Full Text] [Related]
3. The course of neuroendocrine differentiation in prostatic carcinomas. An immunohistochemical study testing chromogranin A as an "endocrine marker".
Abrahamsson PA; Falkmer S; Fält K; Grimelius L
Pathol Res Pract; 1989 Sep; 185(3):373-80. PubMed ID: 2813190
[TBL] [Abstract][Full Text] [Related]
4. Human chorionic gonadotropin in lung and lung tumors. Immunohistochemical study on unbalanced distribution of subunits.
Fukayama M; Hayashi Y; Koike M; Hajikano H; Endo S; Okumura H
Lab Invest; 1986 Oct; 55(4):433-43. PubMed ID: 2429065
[TBL] [Abstract][Full Text] [Related]
5. Peptide hormones, serotonin, and other cell differentiation markers in benign hyperplasia and in carcinoma of the prostate.
Abrahamsson PA; Alumets J; Wadström LB; Falkmer S; Grimelius L
Prog Clin Biol Res; 1987; 243A():489-502. PubMed ID: 2443920
[No Abstract] [Full Text] [Related]
6. Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma.
Aprikian AG; Cordon-Cardo C; Fair WR; Reuter VE
Cancer; 1993 Jun; 71(12):3952-65. PubMed ID: 7685237
[TBL] [Abstract][Full Text] [Related]
7. Carcinoma of the prostate with Cushing's syndrome. A case report with histochemical and chemical demonstration of immunoreactive corticotropin-releasing hormone in plasma and tumoral tissue.
Fjellestad-Paulsen A; Abrahamsson PA; Bjartell A; Grino M; Grimelius L; Hedeland H; Falkmer S
Acta Endocrinol (Copenh); 1988 Dec; 119(4):506-16. PubMed ID: 3264436
[TBL] [Abstract][Full Text] [Related]
8. [Immunohistochemical study of neuroendocrine cells and prostate-specific antigen in prostate carcinoma].
Yao GY; Lai MD; Chen PH
Zhonghua Yi Xue Za Zhi; 1994 Mar; 74(3):161-2, 191-2. PubMed ID: 7522941
[TBL] [Abstract][Full Text] [Related]
9. [Immunohistological demonstration of peptide hormones and serotonin in ovarian mucinous and endometrioid tumors with argyrophil cells].
Inoue Y; Ueda G; Yamasaki M; Inoue M; Tanaka Y; Nishino T; Saito J; Abe Y; Tanizawa O
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Mar; 38(3):361-5. PubMed ID: 2871119
[TBL] [Abstract][Full Text] [Related]
10. Glycoprotein hormone alpha-chain-immunoreactive endocrine cells in prostate and cloacal-derived tissues.
Fetissof F; Arbeille B; Guilloteau D; Lanson Y
Arch Pathol Lab Med; 1987 Sep; 111(9):836-40. PubMed ID: 2443105
[TBL] [Abstract][Full Text] [Related]
11. Immunohistological demonstration of calcitonin in endometrial carcinomas with and without argyrophil cells.
Ueda G; Yamasaki M; Inoue M; Tanaka Y; Kurachi K
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jul; 32(7):960-4. PubMed ID: 6165793
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical demonstration of peptide hormones in endometrial carcinomas.
Inoue M; Ueda G; Yamasaki M; Tanaka Y; Hiramatsu K
Cancer; 1984 Nov; 54(10):2127-31. PubMed ID: 6149014
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary carcinoids. Immunohistochemical demonstration of brain-gut peptides.
Yang K; Ulich T; Taylor I; Cheng L; Lewin KJ
Cancer; 1983 Sep; 52(5):819-23. PubMed ID: 6191855
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine differentiation in prostatic carcinomas. A retrospective autopsy study.
Turbat-Herrera EA; Herrera GA; Gore I; Lott RL; Grizzle WE; Bonnin JM
Arch Pathol Lab Med; 1988 Nov; 112(11):1100-5. PubMed ID: 2460064
[TBL] [Abstract][Full Text] [Related]
15. Prostatic carcinoma with endocrine features. A report of a neoplasm containing multiple immunoreactive hormonal substances.
Rojas-Corona RR; Chen LZ; Mahadevia PS
Am J Clin Pathol; 1987 Dec; 88(6):759-62. PubMed ID: 2891293
[TBL] [Abstract][Full Text] [Related]
16. Neoplastic endocrine cells in prostatic carcinoma: a case report with immunocytochemical and electron microscopic findings.
Watanabe K; Hoshi N; Hiraki H; Yamaki T; Tsu-Ura Y; Suzuki T
Fukushima J Med Sci; 1995 Jun; 41(1):51-60. PubMed ID: 8606042
[TBL] [Abstract][Full Text] [Related]
17. Endometrial carcinoma with argyrophil cells: a histochemical and immunohistochemical analysis.
Aguirre P; Scully RE; Wolfe HJ; DeLellis RA
Hum Pathol; 1984 Mar; 15(3):210-7. PubMed ID: 6141992
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands.
Abrahamsson PA; Lilja H; Falkmer S; Wadström LB
Prostate; 1988; 12(1):39-46. PubMed ID: 2450341
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine components of the bronchopulmonary tract: hyperplasias, dysplasias, and neoplasms.
Gould VE; Linnoila RI; Memoli VA; Warren WH
Lab Invest; 1983 Nov; 49(5):519-37. PubMed ID: 6138458
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical staining and serotest markers during development of a sarcomatoid and small cell prostate tumor.
Frković-Grazio S; Kraljić I; Trnski D; Tarle M
Anticancer Res; 1994; 14(5B):2151-6. PubMed ID: 7840515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
